Toyoda Gosei Co., Ltd. (TOKYO:7282) has invested* in ThinkCyte K.K., whose technologies are used for a broad spectrum of applications, including the early detection of leukemia and other diseases, with the aim of solving social issues in the healthcare field.
Amberen, a pioneering company in menopause innovation, is redefining standards for menopausal relief with the introduction of its new Amberen Advanced Menopause Relief Gummy. Like the existing capsule formulation, the new gummies target the root cause of physical and emotional menopause symptoms by helping the body to self-regulate its own hormone production for multi-symptom relief and comfort all day and night.
Flexan LLC, a custom contract manufacturer of medical grade silicone and thermoplastic components, and ILC Dover, a leading provider of innovative single-use solutions for biopharmaceutical and pharmaceutical processing, announced that they have successfully attained ISO 13485:2016 certification for a 15,000 sq. ft. Class 7 cleanroom facility located in Juarez, Mexico. This milestone marks a significant advancement in delivering high-quality, nearshoring solutions to medical device and pharmaceutical customers.
Daewoong confirmed the approval from the Ministry of Food and Drug Safety (MFDS) for a phase 1 clinical trial plan for its investigational product DWRX2008. The inaugural study, set for Q4 of 2023, will assess the safety and pharmacokinetics of DWRX2008 across diverse dosages in both healthy Korean and Caucasian subjects.
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook Industries, a manufacturer of single-use filling needles and molded fluid path assemblies for pharma and biopharma fill-finish machinery.
CIONIC, the innovative bionic clothing company dedicated to improving mobility with the breakthrough FDA-cleared Cionic Neural Sleeve, was recognized with multiple top awards at the 2023 International Design Excellence Awards (IDEA) by the Industrial Designers Society of America (IDSA), including a gold award for Digital Interaction, and a silver for design in the Medical & Health category.
OZTx, with the aim of social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation), is conducting research and development of regenerative medicine using iPS cell-derived cardiomyocytes and islet cells and supports commercialization of development candidate seeds through collaboration with commercial partnerships and academic institutions.
Pain Insights conducted a patient-centered survey to better understand the needs of patients with recurrent and chronic pain, review pain management needs in potentially vulnerable patient populations across the lifespan, such as Veterans, the elderly, unborn children, and those with genetic diseases, and to present information on potential pain-related initiatives.
Lysando, the leading pioneer in the field of antimicrobial proteins has achieved significant milestones with its cutting-edge Artilysin® technology.
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, unveiled today Vertiva™, the latest release of its patented On-Body Delivery System (OBDS).